Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $142,492 - $232,529
-631 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $140,018 - $305,700
631 New
631 $242,000
Q1 2021

May 12, 2021

SELL
$109.18 - $185.98 $51,860 - $88,340
-475 Closed
0 $0
Q4 2020

Jan 11, 2021

BUY
$65.74 - $169.86 $20,576 - $53,166
313 Added 193.21%
475 $49,000
Q3 2020

Oct 09, 2020

BUY
$54.34 - $94.85 $8,803 - $15,365
162 New
162 $11,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.